Guided Therapeutics - GTHP Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Guided Therapeutics - GTHP

GTHP 0.270

0.0%

Nov 4 3:07 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Robin who wrote (10)	5/14/1998 11:23:00 AM
From: Cacaito	Read Replies (1) of 118

I tested both Bilicheck on myself and friends, and CCSI (Colormate?) at the New Orleans meeting of the Pediatric Research Societies (May 1 to 5) and did not find any major difference between them in terms of technology or ease of use. The Bilicheck has a small extra piece for control (and it costs some additional money). Both will sell in the $3,000 range. Patient bill expenses will be covered by insurance companies for both (very important). There were several poster presentations about the use of both instruments with good results in newborn babies. Respironics booth was also promoting Bilicheck at the meeting in New Orleans.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next